We support diverse sequencing and genomic technologies for use in IVD diagnostics development in the fields of oncology, infectious diseases, and heritable diseases. If you are looking for a specific technology not found below, please contact us
Next Generation Sequencing
Avenio Targeted Panel: This allows for the analysis of 17 oncology related genes, including those published in the National Comprehensive Cancer Network (NCCN) guidelines.
Avenio Expanded Panel: The expanded panel includes the 17 NCCN guideline related genes as well as 60 additional biomarkers that are currently being analyzed in oncology clinical trials to determine their utility
Avenio Surveillance Panel: True to its name the surveillance panel has been optimized with the guideline genes as well as 180 additional genes to allow for longitudinal analysis that monitors tumor burden (TMB) and minimal residual disease (MRD).
The TruSight Oncology (TSO) 500 panel: The TSO panel is designed for the SNV, Indel, CNV and fusion analysis of 523 oncology related genes making it a great biomarker discovery tool. It also analyzes Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI).
Quantitative Real-Time PCR (qRTPCR)
FISH: RNA or DNA
Cell & Tissue Methodologies
We support anatomic pathology, liquid cell sorting and enrichment, and cytogenetics techniques deployed for various applications, particularly oncology.
Cell Sorting & Enrichment
We support diverse technologies for IVD development and scale-up activities that may require automated DNA extraction and liquid-handling systems.
| || |
EXO-NET® Pan-Exosome Capture
EXO-NET® Pan-Exosome Capture is an immunoaffinity magnetic bead-based isolation system for exosome isolation from plasma, serum, urine, saliva and cell-conditioned medium.
EXO-NET is the highest-efficiency exosome isolation solution available
EXO-NET is Compatible for use with the following downstream applications:
To discuss your individual project needs, please contact us.